ArticleNPJ digital medicine2026
Validating the ADFSCI hypotension symptom domain as a scalable patient reported outcome measure in spinal cord injury.
Article in NPJ digital medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
20 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Hypotension is an under-recognized consequence of spinal cord injury (SCI). Clinical assessments, such as head-up tilt testing, are resource-intensive and carry safety risks. In this study, we evaluated the validity of the hypotension symptom domain of the Autonomic Dysfunction Following Spinal Cord Injury (ADFSCI) questionnaire as a patient-reported outcome measure for hypotension-related symptoms in individuals with SCI. Known-groups validity and convergent validity were supported by higher hypotension symptom scores in participants with physiologically defined orthostatic hypotension (OH). Discriminative performance for OH classification was acceptable, and symptom frequency, severity, and contextual triggers were each associated with greater physiological BP instability. Symptom-level analyses identified blurred vision, light-headedness, fatigue, weakness, and dizziness correlated with blood pressure declines. To assess real-world applicability, we also analyzed a global dataset of patient-reported ADFSCI responses from individuals with SCI, enabling population-scale characterization of hypotensive symptom burden. In this dataset, higher symptom scores were associated with female sex and higher neurological injury level. Together, these findings provide converging evidence of supporting the validity of the hypotension symptom domain as a scalable measure of hypotension symptom burden in SCI for use in remote assessment and screening.
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.